Trials / Completed
CompletedNCT01764295
Clinical Study for Patients With Hypertension Associated With Dyslipidemia
Multi-institutional, Randomized, Double-Blind, Placebo-Control, Factorial Design, 4-arms, 8 Week Administration, Phase 3 Clinical Study for Patients With Hypertension Associated With Dyslipidemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of DWJ1276
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1276 | |
| DRUG | Olmesartan | |
| DRUG | Rosuvastatin | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-05-01
- Completion
- 2013-07-01
- First posted
- 2013-01-09
- Last updated
- 2013-08-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01764295. Inclusion in this directory is not an endorsement.